| abstract |
This specification is a novel ginsenoside (20S, 24R) -6-O-β-D-glucopyranosyl (1-> 2) -β-D-glucopyranoside-damar-3-one-20, 24-epoxy-6a, 12b, 25-triol ((20S, 24R) -6-O-β-D-glucopyranosyl (1-> 2) -β-D-glucopyranoside-dammar-3-one-20,24 -epoxy-6a, 12b, 25-triol), a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition shows excellent blood circulation improving effect. |